Mitochondrial Peroxiredoxins and Monoamine Oxidase-A: Dynamic Regulators of ROS Signaling in Cardioprotection

Overview

Journal Physiol Res

Date 2025 Feb 4

PMID 39903882

Authors

M Ferko

P Alanova

D Janko

B Opletalova

N Andelova

Affiliations

Soon will be listed here.

Abstract

An excessive increase in reactive oxygen species (ROS) levels is one of the main causes of mitochondrial dysfunction. However, when ROS levels are maintained in balance with antioxidant mechanisms, ROS fulfill the role of signaling molecules and modulate various physiological processes. Recent advances in mitochondrial bioenergetics research have revealed a significant interplay between mitochondrial peroxiredoxins (PRDXs) and monoamine oxidase-A (MAO-A) in regulating ROS levels. Both proteins are associated with hydrogen peroxide (H2O2), MAO-A as a producer and PRDXs as the primary antioxidant scavengers of H2O2. This review focuses on the currently available knowledge on the function of these proteins and their interaction, highlighting their importance in regulating oxidative damage, apoptosis, and metabolic adaptation in the heart. PRDXs not only scavenge excess H2O2, but also act as regulatory proteins, play an active role in redox signaling, and maintain mitochondrial membrane integrity. Overexpression of MAO-A is associated with increased oxidative damage, leading to mitochondrial dysfunction and subsequent progression of cardiovascular diseases (CVD), including ischemia/reperfusion injury and heart failure. Considering the central role of oxidative damage in the pathogenesis of many CVD, targeting PRDXs activation and MAO-A inhibition may offer new therapeutic strategies aimed at improving cardiac function under conditions of pathological load related to oxidative damage. Keywords: Mitochondria, Peroxiredoxin, Monoamine oxidase-A, Reactive oxygen species, Cardioprotective signaling.

References

Kaludercic N, Carpi A, Menabo R, Di Lisa F, Paolocci N . Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury. Biochim Biophys Acta. 2010; 1813(7):1323-32. PMC: 3030628. DOI: 10.1016/j.bbamcr.2010.09.010. View

Maharjan S, Oku M, Tsuda M, Hoseki J, Sakai Y . Mitochondrial impairment triggers cytosolic oxidative stress and cell death following proteasome inhibition. Sci Rep. 2014; 4:5896. PMC: 4116626. DOI: 10.1038/srep05896. View

Aldosari S, Awad M, Harrington E, Sellke F, Abid M . Subcellular Reactive Oxygen Species (ROS) in Cardiovascular Pathophysiology. Antioxidants (Basel). 2018; 7(1). PMC: 5789324. DOI: 10.3390/antiox7010014. View

Murarikova M, Ferko M, Waczulikova I, Jasova M, Kancirova I, Murinova J . Changes in mitochondrial properties may contribute to enhanced resistance to ischemia-reperfusion injury in the diabetic rat heart. Can J Physiol Pharmacol. 2017; 95(8):969-976. DOI: 10.1139/cjpp-2017-0211. View

Atici A, Crother T, Noval Rivas M . Mitochondrial quality control in health and cardiovascular diseases. Front Cell Dev Biol. 2023; 11:1290046. PMC: 10657886. DOI: 10.3389/fcell.2023.1290046. View

Korn A, Eichler H, Fischbach R, Gasic S . Moclobemide, a new reversible MAO inhibitor--interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients. Psychopharmacology (Berl). 1986; 88(2):153-7. DOI: 10.1007/BF00652232. View

Ugun-Klusek A, Theodosi T, Fitzgerald J, Burte F, Ufer C, Boocock D . Monoamine oxidase-A promotes protective autophagy in human SH-SY5Y neuroblastoma cells through Bcl-2 phosphorylation. Redox Biol. 2018; 20:167-181. PMC: 6197572. DOI: 10.1016/j.redox.2018.10.003. View

Qausain S, Basheeruddin M . Unraveling the Peroxidase Activity in Peroxiredoxins: A Comprehensive Review of Mechanisms, Functions, and Biological Significance. Cureus. 2024; 16(8):e66117. PMC: 11370188. DOI: 10.7759/cureus.66117. View

Enomoto H, Mittal N, Inomata T, Arimura T, Izumi T, Kimura A . Dilated cardiomyopathy-linked heat shock protein family D member 1 mutations cause up-regulation of reactive oxygen species and autophagy through mitochondrial dysfunction. Cardiovasc Res. 2020; 117(4):1118-1131. DOI: 10.1093/cvr/cvaa158. View

10.

Santin Y, Fazal L, Sainte-Marie Y, Sicard P, Maggiorani D, Tortosa F . Mitochondrial 4-HNE derived from MAO-A promotes mitoCa overload in chronic postischemic cardiac remodeling. Cell Death Differ. 2019; 27(6):1907-1923. PMC: 7244724. DOI: 10.1038/s41418-019-0470-y. View

11.

Murry C, Jennings R, Reimer K . Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74(5):1124-36. DOI: 10.1161/01.cir.74.5.1124. View

12.

MacAulay K, Woodgett J . Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes. Expert Opin Ther Targets. 2008; 12(10):1265-74. PMC: 4485462. DOI: 10.1517/14728222.12.10.1265. View

13.

Mailloux R . Mitochondrial Antioxidants and the Maintenance of Cellular Hydrogen Peroxide Levels. Oxid Med Cell Longev. 2018; 2018:7857251. PMC: 6051038. DOI: 10.1155/2018/7857251. View

14.

Barrera G, Pizzimenti S, Daga M, Dianzani C, Arcaro A, Cetrangolo G . Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders. Antioxidants (Basel). 2018; 7(8). PMC: 6115986. DOI: 10.3390/antiox7080102. View

15.

Kasparova D, Neckar J, Dabrowska L, Novotny J, Mraz J, Kolar F . Cardioprotective and nonprotective regimens of chronic hypoxia diversely affect the myocardial antioxidant systems. Physiol Genomics. 2015; 47(12):612-20. DOI: 10.1152/physiolgenomics.00058.2015. View

16.

Cardozo G, Mastrogiovanni M, Zeida A, Viera N, Radi R, Reyes A . Mitochondrial Peroxiredoxin 3 Is Rapidly Oxidized and Hyperoxidized by Fatty Acid Hydroperoxides. Antioxidants (Basel). 2023; 12(2). PMC: 9952270. DOI: 10.3390/antiox12020408. View

17.

Duicu O, Lighezan R, Sturza A, Balica R, Vaduva A, Feier H . Assessment of Mitochondrial Dysfunction and Monoamine Oxidase Contribution to Oxidative Stress in Human Diabetic Hearts. Oxid Med Cell Longev. 2016; 2016:8470394. PMC: 4846770. DOI: 10.1155/2016/8470394. View

18.

Zhu W, Wu X, Zhang Y, Zhou Z . Proteomic analysis of mitochondrial proteins in cardiomyocytes from rats subjected to intermittent hypoxia. Eur J Appl Physiol. 2011; 112(3):1037-46. DOI: 10.1007/s00421-011-2050-9. View

19.

Manni M, Rigacci S, Borchi E, Bargelli V, Miceli C, Giordano C . Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target. Oxid Med Cell Longev. 2017; 2016:4375418. PMC: 5156804. DOI: 10.1155/2016/4375418. View

20.

Sharapov M, Goncharov R, Filkov G, Trofimenko A, Boyarintsev V, Novoselov V . Comparative Study of Protective Action of Exogenous 2-Cys Peroxiredoxins (Prx1 and Prx2) Under Renal Ischemia-Reperfusion Injury. Antioxidants (Basel). 2020; 9(8). PMC: 7465264. DOI: 10.3390/antiox9080680. View